Mellem 95, 2% og 97, 4% af de patienter, der får Cetrotide, oplever ingen LH stigning (procentandelene var 98% og 97, 2% for henholdsvis buserelin og triptorelin).
Between 95.2% and 97.4% of patients receiving Cetrotide has no LH surge (the percentages were 98% and 97.2% for buserelin and triptorelin, respectively).